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Prolactin, cortisol and thyroxine levels
and the premature infant
N. J. BLUMENTHAL, L. A. VAN DER WALT, E. GORDON, O. LANGER
Summary
The relationship of prolactin, cortisol and thyroxine
values in cord and maternal plasma to fetal age and
weight and to the incidence of hyaline membrane
disease (HMD) was investigated in 80 neonates of
whom 40 were born at more than 37 weeks' gesta-
tion. Of the 40 born at less than 36 weeks 11 deve-
loped HMD. Serum cortisol has been shown to be a
differentiating factor for HMD, but cord thyroxine
and prolactin levels seem to be related more to age
and weight than to the occurrence of HMD.
S Atr Med J 1983;·63: 605-606.
Hyaline membr<lne disease (HMD) is widely accepted as the
major cause of morbidity and mortality in premature infants. l
This condition of functional immaturity of the lungs is thought
to be associated mainly with inadequate alveolar surfactant, a
surface-active material which lines the alveoli and reduces sur-
face tension at the alveolar tissue/air interface. l The regulatory
mechanisms controlling lecithin synthesis, particularly those
responsible for the surge in lecithin production in the late stages
of gestation, are not fully understood.
The cortisol levels in amniotic fluid correlate well with gesta-
tional age. 2 It has been shown by MurphyJ. that mean cord
cortisol levels in infants with HMD are significantly lower than
those in infants ofsimilar gestational age without HMD. Specific
glucocorticoid receptors have been found in fetal lung,4.5 further
suggesting that glucocorticoids are related to lung maturation.
It has been shown by Winters er al. 6 that the concentration of
prolactin in human fetal plasma increases throughout preg-
nancy, with a marked rise towards term. This finding suggests
that plasma prolactin may be correlated with the presence or
absence of HMD in the neonate. This premise was investigated
by Hauth er al., 7 who found a correlation between a low level of
prolactin and the development of HMD. .
The appearance of and progressive rise in fetal thyroxine take
place at the same time as the earliest production of pulmonary
surfactant and its subsequent increasing concentration.s Since
thyroxine has been shown to be an important regulator of lipid
metabolism in vivo, several researchers have investigated the
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pos ibility that it may be involved in regulating the production or
metabolism of surfactant.9. 1O
The present tudy was designed to approach these problems
by determining the prolactin, cortisol and thyroxine levels at
delivery in maternal blood and cord blood-of infants delivered
preterm (before 36 weeks' gestation) and at t~rm (after 37 weeks'
gestation).
Patients, material and methods
The subjects were infants delivered at Coronation Hospital,
Johannesburg, and their mothers. Of the 80 neonates studied 40
were judged to have gestational ages of more than 37 weeks (the
mature group), whereas the other 40 had gestational ages of less
than 36 weeks (the preterm group). In the preterm group II
infants (27%) developed HMD, while the other 29 had normal
lung function.
None of the patients in either group suffered any complica-
tions of pregnancy or labour. No pregnancy had been compli-
cated by pregnancy-induced hypertension, diabetes, premature
rupture of membranes, pyrexia or multiple pregnancy. No deli-
\'ery was by caesarean section.
Prolactin, cortisol and thyroxine values were determined in
maternal and mixed cord blood samples taken at the time of
delivery. Prolactin levels were determined by a radio-immuno-
as ay technique for the quantitative determination of prolactin in
serum manufactured by Abbott Laboratories. Serum cortisol
and thyroxine levels were both determined by radio-immunoassay
kits manufactured by Clinical Assays.
Estimation of gestational age
Gestational age was estimated by dates, uterine size at the first
antenatal visit and ultrasonography. Fetal age was also assessed
by an experienced neonatologist using the Dubowitz score.
Diagnosis of hyaline membrane disease
The diagnosis of HMD was made by the neonatologist. His
diagnosis was based on tachypnoea, inspirawry retracrl!1l1, cya-
nosis, respiratory acidosis and chest radiographs. Th"~e cases in
which hyaline membrane disease could not be distinguished
unequivocally from other forms of respiratory distress were not
included in the study.
Results
The mean weights (± SD) of the mature group, the non-HMD
group and the HMD group were 2961 ± 346,9 g, 1820 ± 328 g
and 1448, I ± 360 g. The difference between these groups was
statistically significant (P < 0,0 I). The mean gestational age of
the mature infants was 38,1 ± 1,1 weeks, while those of the
non-HMD and HMD groups were 32,9 _ 1,3 and 31,5 _ 1,7
weeks respectively.
Cord thyroxine values in the mature, non-HMD and HMD
groups were 15,3 ± 4,2,11,9 _ 7,7 and 9,9 ± 3,3 nmol/I. There
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was a statistically significant difference between the mature and
preterm groups (P < 0,01) but not betweeen the non-HMD and
HMD groups. Maternal thyroxine levels for the three groups
were 13,3 ± 14,5,8,8 ± 4,7 and 11,43 ± 2,01 nmol/I.
Cord cortisol le\'els were 19,3 ± 9,2, 19,2 ± 19,2 and 13, I ±
10,8 mg/ml in the mature, non-HMD and HMD groups. There
was a statistically significant difference between the marure and
HMD gropus (P < 0,05). Maternal cortisol values were 54,4 ±
28,4, 43,5 ± 25,5 and 58,6 ± 25,4 mg/ml in the marure, non-
HMD and HMD groups.
Cord prolactin \'alues were 281,6 ± 134,5, 198,0 ± 140,7 and
225,1 ± 119,9 mg/ml in the marure, non-HMD and HMD
groups. There was a statistically significant difference (P < 0,01)
between the mature group and the combined preterm group as
well as between the mature and HMD groups. Maternal prolac-
tin le\'els were 225,7 ± 183,4, 158,3 ± 137,7 and 141,0 ± 87,3
mg/ml; there were statistically significant differences between
the marure group and the combined preterm group (P < 0,04)
and between the marure and HMD groups (P < 0,03).
Cord blood prolactin le\'els have been shown by Hauth el al. 7
and Smith el al. 11 to correlate significantly with the weights of
the newborn infants as well as with their gestational ages. They
also showed that cord plasma prolactin levels in infants who
de\'eloped HMD were low.
Our results showed that mean cord prolactin levels were lower
in both preterm groups than in the mature group. However, only
the differences between the mature group and the combined
preterm group and between the control group and the non-
HMD group reached statistical significance. The difference
between the mature and H MD groups alone was not statistically
significant. This shows that the lower cord prolactin levels in the
preterm group are related only to prematurity (weight and age)
and not specifically to HMD. These results are similar to those of
Hauth el al. ; and Smith ec al. 11
lv1aternal prolactin levels were markedly lower in the preterm
group than in the mature group. There is a significant difference
between the mature group and both the HMD group and the
combined preterm group, but none between the mature group
and the non-HMD group. This indicates that the maternal
serum prolactin level is related to prematurity as a whole, and in
addition is specifically related to the respiratory distress
syndrome.
. When the HMD group and the non-HMD groups are com-
pared, statistically significant differences are only seen between
the cord corti 01 le\'els in the HMD group and those in the
mature group. A statistically significant increase in serum cord
thyroxine and prolactin values with an increase in weight has also
been demonstrated.
Although not statistically significant, there was a mean fall in
cord cortisol and thyroxine levels between the HMD and non-
HMD groups, with an increase in cord prolactin between these
two groups.
Low serum cord cortisol values are therefore a differentiating
factor for HMD, but cord thyroxine and cord prolactin levels
seem to be related more to weight and gestational age than to the
presence of HMD.
Discussion
Mean weights and ages were significantly lower in the preterm
group than in the mature group; furthermore, the infants with
HMD weighed significantly less than the preterm infants with-
out HMD. Mean cord serum thyroxine levels rose significantly
with age and weight (preterm v. mature), but not wit4in the
preterm group. This supports the work of Fisher el al. 10 indica-
ting a rise in fetal thyroxine values with weight and age. M~ternal
serum thyroxine values did not differ significantly between any
of the groups studied.
Klein el at. 12 and his associates found higher cortisol levels in
infants with HMD than in controls; in contrast Murphy3 des-
cribed significantly lower cord cortisol levels in infants with
H1V1D than in controls.
In our srudy there was no difference between cord cortisol
levels in the mature and the non-HMD preterm groups. How-
ever, there was a statistically significant reduction in level in the
HMD group compared with the marure group. This contradicts
the findings of Klein el al. 12 but supports those of Muiphy. 3
There is no statistically significant relationship between mat-
ernal cortisol values.
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